Spectral Historical Income Statement
| EDT Stock | CAD 0.56 0.01 1.75% |
Historical analysis of Spectral Med income statement accounts such as Selling General Administrative of 8.1 M or Total Revenue of 1.5 M can show how well Spectral Med performed in making a profits. Evaluating Spectral Med income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Spectral Med's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Spectral Med latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Spectral Med is a good buy for the upcoming year.
Spectral |
About Spectral Income Statement Analysis
Spectral Med Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Spectral Med shareholders. The income statement also shows Spectral investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Spectral Med Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Revenue
Total revenue comprises all receipts Spectral Med generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Spectral Med. It is also known as Spectral Med overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Spectral Med operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Spectral Med is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Spectral Med's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Spectral Med current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Spectral Med. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Spectral Med's Interest Expense is very stable compared to the past year. As of the 27th of November 2024, Research Development is likely to grow to about 4.9 M, while Depreciation And Amortization is likely to drop about 207.1 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.2M | 983K | 662K | 628.9K | Total Revenue | 2.1M | 1.7M | 1.6M | 1.5M |
Spectral Med income statement Correlations
Click cells to compare fundamentals
Spectral Med Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Spectral Med income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 278K | 304K | 294K | 272K | 218K | 207.1K | |
| Interest Expense | 36K | 32K | 28K | 104K | 1.3M | 1.4M | |
| Selling General Administrative | 6.7M | 10.1M | 9.4M | 8.0M | 11.0M | 8.1M | |
| Total Revenue | 2.9M | 2.1M | 2.1M | 1.7M | 1.6M | 1.5M | |
| Gross Profit | 2.2M | 1.5M | 1.2M | 983K | 662K | 628.9K | |
| Other Operating Expenses | 7.6M | 11.0M | 10.6M | 8.9M | 13.0M | 9.3M | |
| Operating Income | (4.7M) | (9.1M) | (8.6M) | (9.4M) | (11.4M) | (12.0M) | |
| Ebit | (4.8M) | (9.1M) | (6.9M) | (7.5M) | (14.2M) | (14.9M) | |
| Ebitda | (4.5M) | (8.8M) | (6.6M) | (7.2M) | (14.0M) | (13.3M) | |
| Total Operating Expenses | 7.0M | 10.4M | 9.7M | 8.2M | 6.6M | 8.1M | |
| Net Income | (4.9M) | (9.0M) | (8.7M) | (11.3M) | (15.7M) | (14.9M) | |
| Income Tax Expense | 893K | 8K | (116K) | 1.7M | 155K | 162.8K | |
| Income Before Tax | (4.9M) | (9.1M) | (8.8M) | (9.6M) | (15.5M) | (14.7M) | |
| Total Other Income Expense Net | (97K) | (157K) | (302K) | 819K | (4.1M) | (3.9M) | |
| Cost Of Revenue | 650K | 628K | 832K | 684K | 936K | 1.2M | |
| Net Income From Continuing Ops | (4.9M) | (9.1M) | (8.8M) | (9.6M) | (15.5M) | (14.7M) | |
| Net Income Applicable To Common Shares | (4.9M) | (9.1M) | (8.8M) | (11.3M) | (12.9M) | (13.6M) | |
| Reconciled Depreciation | 278K | 304K | 294K | 272K | 218K | 285.7K |
Pair Trading with Spectral Med
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.Moving against Spectral Stock
| 0.89 | PYPL | PayPal Holdings CDR | PairCorr |
| 0.84 | INTC | INTEL CDR | PairCorr |
| 0.74 | TSLA | Tesla Inc CDR | PairCorr |
| 0.73 | NVDA | NVIDIA CDR | PairCorr |
| 0.65 | GOOG | Alphabet CDR | PairCorr |
The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Spectral Stock
Spectral Med Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Spectral Med shareholders. The income statement also shows Spectral investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).